Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE
Background: Hyperfunctional platelets play important roles in thromboembolism in patients with β-thalassaemia/ haemoglobin E (β-thal/HbE). Our previous study revealed ex vivo inhibitory effects of deferiprone on normal platelets. Herein, we aimed to investigate the in vivo effects on platelets in pa...
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
BioExcel Publishing Ltd
2022-12-01
|
| シリーズ: | Drugs in Context |
| 主題: | |
| オンライン･アクセス: | https://www.drugsincontext.com/deferiprone-an-iron-chelator-alleviates-plateletbrhyperactivity-in-patients-with-%ce%b2-thalassaemia-hb-e/ |